Called to Be
Greetings. We had an interesting weekend, as we headed up to Manhattan to see our niece perform in the show “Titanique,” which she co-wrote and in which she also has the lead role. Her image is plastered on posters in Penn Station and on the sides of buses. We are so proud of her. It is eerie but impossibly sweet to remember her as a 3-year-old spontaneously hopping onto tables in restaurants to belt out the song “Tomorrow” from the musical “Annie.” I guess I really can say that she was called to be a singer and stage performer. It was a marvelous evening of theater.
I worked on the CCSG on the trains to and from New York; I was going to focus on another CCSG-relevant section in this blog, but then this happened.
|
|
Study Finds Relationship Between Discrimination and Frailty in Black Cancer Survivors
Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study by a research team at Georgetown Lombardi and the Barbara Ann Karmanos Cancer Institute in Detroit led Jeanne Mandelblatt, MD, MPH, director of the Georgetown Lombardi Institute for Cancer and Aging Research, and including Lucile Adams-Campbell, PhD, professor of oncology and associate director for Minority Health and Health Disparities Research. Read more about this research.
|
|
Georgetown Lombardi Members Recognized with Vicennial Gold Medal
Several Georgetown Lombardi members and associated staff received Vicennial Gold Medals at Georgetown University’s Spring Faculty Convocation on March 21. Established 73 years ago, the Vicennial Medal is an award granted in recognition of 20 years of service to Georgetown. Those honored included:
-
Chris Albanese, PhD, professor of oncology and radiology and director of the Preclinical Imaging Research Laboratory and the Center for Translational Imaging
-
Olga C. Rodriguez, PhD, associate professor of oncology and co-director of the Preclinical Imaging Research Laboratory
-
Judy Huei-yu Wang, PhD, associate professor of oncology and a member of the Cancer Prevention and Control Program
-
G. William Rebeck, PhD, professor in the Department of Neuroscience
-
Sharon Graham, a chaplain to pediatric oncology patients at MedStar Georgetown University Hospital
|
|
Reminder: Complete the Global Oncology Survey
Please complete the survey that was distributed last week by the Office for Global Oncology by April 1. Doing so will help create an inventory all global oncology related work being done across Georgetown Lombardi. Go to the survey.
|
|
Georgetown Lombardi Arts & Humanities Program Issues Call for Art: “Art for a Cause”
The Arts & Humanities Program invites the community to submit artwork for “Art for a Cause,” a project held in conjunction with World Collage Day (May 13) 2023. Submit 4x4-inch collage art to be displayed at MedStar Georgetown, then attached to blank greeting cards and made available to patients, their families, caregivers, and hospital staff. (Work will not be returned or sold.) View more information here, including how to submit artwork. Learn more at an online info session on Saturday, April 8, 12:00 – 1:00 p.m. Register for the info session. Email questions to jenniferwilkinpenick@gmail.com.
|
|
Shared Resources Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Shared Resource Spotlight: Histopathology and Tissue Shared Resource
The Histopathology and Tissue Shared Resource (HTSR) provides Georgetown Lombardi investigators with access to comprehensive laboratory and interpretive pathology services and access to human tissue for translational research. The HTSR facilitates innovative cancer research by collecting and distributing high-quality, clinically annotated human tissue and liquid biospecimens. The HTSR also provides comprehensive histology services, including tissue processing, paraffin and frozen section microtomy, staining, immunohistochemistry (including quantitative multiplex), immunofluorescence, as well as tissue microarray (TMA) construction, staining and interpretative analysis. Additional services include quantitative automated brightfield and immunofluorescence image analysis, immunophenotyping, miRNA in situ staining, and support for newly acquired molecular platforms (RNAscope, Nanostring GeoMx Digital Spatial Profiler, and Standard Biotools Imaging Mass Cytometry).
New technology now available: Akoya Biosciences PhenoCycler-Fusion system for single-cell spatial biology allows for multiplex phenotyping of 100+ RNA and protein biomarkers at single-cell resolution across an entire tissue section, including FFPE.
|
|
Monday, March 27
10:00 - 11:00 a.m.
|
|
“Pandemic Preparedness and Response: Lessons Learned from COVID-19” with Anthony S. Fauci, MD
Monday, March 27
5:00 - 6:00 p.m.
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health from 1984 to 2022, will present the Maloy Distinguished Lecture in Global Health. Lecture will be followed by a moderated conversation. Entry is on a first-come, first-served basis. Doors open at 4:00 p.m. All Georgetown community members will be asked to present their GU ID. This event will be held in Lohrfink Auditorium, Hariri Building and livestreamed via the SFS Facebook page.
|
|
Tuesday, March 28
11:00 a.m. - 12:00 p.m.
Francesco R. Simonetti, PhD, MBChB, assistant professor, Division of Infectious Diseases, Johns Hopkins University School of Medicine. Join this event in Med-Dent, NE301 or via Zoom.
|
|
Tuesday, March 28
12:00 - 1:00 p.m.
Presented by Jianping Fu, PhD, professor of mechanical engineering and adjunct professor of biomedical engineering and cell and developmental biology, University of Michigan, Ann Arbor. Sponsored by the Department of Biochemistry. Join this seminar in Basic Science Building, Room 341 or via Zoom.
|
|
Appointments and Promotions Workshop for Clinical Faculty
Tuesday, March 28
5:00 - 6:00 p.m.
The Office of Faculty and Academic Affairs (OFAA) is hosting appointment and promotions workshops to help current or prospective faculty members learn about the criteria for faculty appointment and promotion, the application process, and resources available for faculty development for those interested or on any of the clinical tracks: Clinician Educator, Clinician Scholar, Clinician, Biomedical Scholar, Biomedical Educator. Contact ofaa@georgetown.edu with any questions. Register for this Zoom workshop.
|
|
Wednesday, March 29
1:00 - 2:00 p.m.
A thesis defense will be presented by Chan Nguyen, PhD candidate in the Tumor Biology Program. Mentor: Chunling Yi, PhD. Join this event in-person in the Warwick Evans Conference Room, Building D or via Zoom.
|
|
Thursday, March 30
4:00 - 5:00 p.m.
Presented by Zoltan Arany, MD, PhD, Samuel Bellet Professor of Cardiology; director, Cardiovascular Metabolism Program, Penn Cardiovascular Institute; co-director, Complications Unit, Institute for Diabetes Obesity and Metabolism; chair, Cell Biology Physiology and Metabolism Graduate Program, Perelman School of Medicine, University of Pennsylvania. Join this seminar in the New Research Building Auditorium or via Zoom.
|
|
Friday, March 31
12:00 - 1:00 p.m.
Presented by Michelle Janelsins, PhD, MPH, director, Cancer Control and Psychoneuroimmunology Lab, University of Rochester Medical Center. Join this lecture via Zoom.
|
|
Funding and Award Opportunities |
|
NEW Research With Activities Related to Diversity (ReWARD)
The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories. View more information and application instructions. Application due date: Monday, June 5, at 5:00 p.m.
|
|
ROS1ders Request for Application for ROS1+ Cancer Research Grant
The ROS1+ Cancer Innovation Award funds high-risk, high-reward research projects focused on ROS1+ cancer. The one-year, $75,000 seed grant can be used for preclinical, translational or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or nonprofit research institution anywhere in the world. Submit letter of intent by March 31. Invited applicants must submit full application by June 15. View the RFA. Apply online at ProposalCentral.
|
|
Request for Applications: Pediatric Sarcomas
The Samuel Waxman Cancer Research Foundation, Alan B. Slifka Foundation and Israel Cancer Research Fund are pleased to issue a joint request for applications for collaborative applications focused on fusion-positive pediatric sarcomas. Note: Projects must involve collaboration between two research groups — one in North America and one in Israel — with different but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. One successful collaborative project will be awarded $150,000 per year for two years, or a total of $300,000, with each university-based research group receiving $75,000 per year ($150,000). Proposals will be prioritized for funding based on their potential to contribute to understanding, preventing and effectively treating pediatric sarcomas, with an emphasis on Ewing sarcoma. View full RFA information. Submit letter of intent by 5 p.m. on May 1, to Wylie Tene at wtene@waxmancancer.org.
|
|
Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas as well as more advanced translation research and early stage clinical trials. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Career Development Award, Pre-application due May 2, 5:00 p.m. ET
-
Concept Award, Pre-application due May 2, 5:00 p.m. ET
-
Idea Development Award: Pre-application due May 10, 5:00 p.m. ET
-
Translational Research Award: Pre-application due May 10, 5:00 p.m. ET
|
|
Children’s Cancer Foundation 2023 Call for Proposals
The Children's Cancer Foundation, Inc. (CCF) invites individuals from Maryland, D.C. and Northern Virginia conducting research and/or programs relevant to pediatric cancer to submit proposals for grant award consideration. CCF will be awarding multiple one-year grants for research; one one-year grant for research by a young investigator (Giant Food NextGen Award); and several one-year grants for support of an existing or new program that serves the pediatric cancer community. Applications must be submitted via email or file transfer service to Rose Ann Verrilli: rverrilli@childrenscancerfoundation.org no later than May 7 at 11:59 p.m. ET. Review and download application materials and guidelines.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Rachael Maynard | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: Michelle Janelsins, PhD, MPH, “Advances in Our Understanding of Cancer-related Cognitive Impairment” | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
